Skip to content
GenoLensGenoLens

RFX6

Chr 6q22.1

regulatory factor X6

Aliases:
MGC33442, dJ955L16.1
MANE:
ENST00000332958.3

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Diabetes with additional phenotypes suggestive of a monogenic aetiology

    BIALLELIC, autosomal or pseudoautosomal
  • Familial diabetes

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intestinal failure or congenital diarrhoea

    BIALLELIC, autosomal or pseudoautosomal
  • Monogenic diabetes

    BIALLELIC, autosomal or pseudoautosomal
  • Neonatal diabetes

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

+2 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome

    0.74
  • Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome

    0.73
  • type 2 diabetes mellitus

    0.61
  • diabetes mellitus

    0.50
  • prostate carcinoma

    0.47
  • monogenic diabetes

    0.45
  • prostate cancer

    0.42
  • gestational diabetes

    0.39
  • neurodegenerative disease

    0.35
  • Alzheimer disease

    0.29

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

DNA-binding protein RFX6

Transcription factor required to direct islet cell differentiation during endocrine pancreas development. Specifically required for the differentiation of 4 of the 5 islet cell types and for the production of insulin (PubMed:20148032, PubMed:25497100). Not required for pancreatic PP (polypeptide-producing) cells differentiation. Acts downstream of NEUROG3 and regulates the transcription factors involved in beta-cell maturation and function, thereby restricting the expression of the beta-cell differentiation and specification genes, and thus the beta-cell fate choice. Activates transcription by forming a heterodimer with RFX3 and binding to the X-box in the promoter of target genes (PubMed:20148032). Involved in glucose-stimulated insulin secretion by promoting insulin and L-type calcium channel gene transcription (PubMed:25497100)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.